What is Sleep Number Corporation's earnings per share (EPS)?

Sleep Number Corporation (SNBR) reported diluted earnings per share of -$5.77 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sleep Number Corporation (SNBR) Financials

SNBR

Trailing 12 months to April 4, 2026

Revenue $1.3B -16.7% YoY

Net Income -$173.7M -707.8% YoY

EPS (Diluted) -$5.77 FY2026 annual

Free Cash Flow -$23.7M +15.6% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 4, 2026 Reported May 12, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q1 FY2027, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SNBR SEC filings page.

Sleep Number Corporation (SNBR) reported $1.3B in revenue over the twelve months to Apr 4, 2026, down 16.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNBR FY2026 2026-10-04

Sales have contracted sharply while gross margin stayed near 60.0%, but fixed and financing burdens pushed the company into deeper losses.

From FY2022 to FY2026, revenue fell 35.4% while gross margin remained near 60.0%; operating margin moved from 8.9% to -3.3%. That combination places the strain after production costs: overhead and financing expense are no longer supported by the smaller sales base, rather than the core gross economics disappearing.

The balance sheet is financed with liabilities exceeding recorded assets: FY2026 liabilities were $1.27B against $641.0M of assets, while the current ratio was just 0.2. Negative equity also worsened to $626.3M, leaving little short-term balance-sheet cushion.

Cash generation has weakened alongside earnings, with operating cash flow shifting from $27.1M in FY2024 to -$3.3M in FY2026. Because capital spending also fell in FY2026, negative free cash flow of -$17.7M reflects weak operating cash conversion more than an investment surge.

Financial Health Signals

Financial Health Score 25/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Sleep Number Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Sleep Number Corporation has an operating margin of -3.3%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 29/100. This is down from 1.4% the prior year.

Growth

Sleep Number Corporation's revenue declined 16.1% year-over-year, from $1.7B to $1.4B. This contraction results in a growth score of 7/100.

Leverage

Not available for Sleep Number Corporation, and counted as zero in the overall score.

Liquidity

Sleep Number Corporation's current ratio of 0.15 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Sleep Number Corporation's operations used $3.3M of cash, and capex of $14.4M added to the outflow, for a free cash flow shortfall of $17.7M. This results in a cash flow score of 23/100.

Returns

Altman Z-Score Distress

-0.96

Sleep Number Corporation scores -0.96, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($2.9M) relative to total liabilities ($1.3B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

Sleep Number Corporation passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Sleep Number Corporation reported a net loss of $132.0M while operations used $3.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Sleep Number Corporation reported an operating loss of $46.6M against $49.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$319.0M

YoY-18.9%

QoQ-8.2%

5Y CAGR-10.9%

10Y CAGR-1.0%

Sleep Number Corporation generated $319.0M in revenue in Q1 2027. This represents a decrease of 18.9% from the same quarter a year earlier. Against the prior quarter it is down 8.2%.

EBITDA

-$24.5M

YoY-246.7%

Sleep Number Corporation's EBITDA was -$24.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 246.7% from the same quarter a year earlier.

Net Income

-$50.3M

YoY-481.7%

QoQ+14.1%

Sleep Number Corporation reported -$50.3M in net income in Q1 2027. This represents a decrease of 481.7% from the same quarter a year earlier. Against the prior quarter it is up 14.1%.

EPS (Diluted)

-$2.19

YoY-476.3%

Sleep Number Corporation earned -$2.19 per diluted share (EPS) in Q1 2027. This represents a decrease of 476.3% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow

-$13.2M

YoY-82.6%

QoQ-1951.6%

Sleep Number Corporation recorded an outflow of $13.2M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 82.6% from the same quarter a year earlier. Against the prior quarter it is down 1951.6%.

Cash & Debt

$1.5M

YoY-12.2%

QoQ-12.3%

5Y CAGR-7.9%

10Y CAGR-25.8%

Sleep Number Corporation held $1.5M in cash as of Q1 2027; long-term debt is not reported for that period.

Shares Outstanding

23M

YoY+1.7%

QoQ+0.8%

5Y CAGR-1.2%

10Y CAGR-6.8%

Sleep Number Corporation had 23M shares outstanding in Q1 2027. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

57.9%

YoY-3.3pp

QoQ+2.2pp

5Y change-4.7pp

10Y change-1.4pp

Sleep Number Corporation's gross margin was 57.9% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Operating Margin

-11.6%

YoY-12.0pp

QoQ-9.2pp

5Y change-25.0pp

10Y change-17.2pp

Sleep Number Corporation's operating margin was -11.6% in Q1 2027, reflecting core business profitability. This is down 12.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.2 percentage points.

Net Margin

-15.8%

YoY-13.6pp

QoQ+1.1pp

5Y change-27.5pp

10Y change-19.4pp

Sleep Number Corporation's net profit margin was -15.8% in Q1 2027, showing the share of revenue converted to profit. This is down 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Return on Equity

Not reported for Q1 2027.

Capital Allocation

R&D Spending

$5.3M

YoY-50.9%

QoQ-15.0%

5Y CAGR-16.6%

Sleep Number Corporation invested $5.3M in research and development in Q1 2027. This represents a decrease of 50.9% from the same quarter a year earlier. Against the prior quarter it is down 15.0%.

Share Buybacks

$373K

YoY-33.7%

QoQ+92.3%

5Y CAGR-70.9%

10Y CAGR-38.9%

Sleep Number Corporation spent $373K on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 33.7% from the same quarter a year earlier. Against the prior quarter it is up 92.3%.

Capital Expenditures

$5.4M

YoY+18.3%

QoQ+116.0%

5Y CAGR-14.0%

10Y CAGR-7.8%

Sleep Number Corporation invested $5.4M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 18.3% from the same quarter a year earlier. Against the prior quarter it is up 116.0%.

SNBR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNBR quarterly income statement

Metric	TTM	FY2610-K	FY2410-K	FY2310-K	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Revenue	$1.3B	$1.4B	$1.7B-10.9%	$1.9B-10.7%	$2.1B	$2.2B+17.7%	$1.9B	$1.7B+10.9%	$1.5B+6.0%	$1.4B+10.2%	$1.3B	$1.2B+4.9%	$1.2B	$960.2M+2.7%	$935.0M+25.8%	$743.2M
Cost of Revenue	$560.1M	$578.5M	$679.5M-14.9%	$799.0M-12.4%	$912.0M	$866.1M+23.6%	$700.6M	$646.4M+7.1%	$603.6M+10.3%	$547.1M+9.2%	$501.1M	$472.9M+5.1%	$449.9M	$358.4M+5.9%	$338.4M+24.0%	$272.9M
Gross Profit	$777.0M	$833.0M	$1.0B-7.9%	$1.1B-9.5%	$1.2B	$1.3B+14.1%	$1.2B	$1.1B+13.4%	$928.0M+3.4%	$897.3M+10.8%	$810.2M	$740.8M+4.8%	$706.9M	$601.8M+0.9%	$596.5M+26.8%	$470.3M
R&D Expenses	$28.4M	$33.9M	$45.3M-18.9%	$55.8M-9.3%	$61.5M	$58.5M+43.1%	$40.9M	$35.0M+21.5%	$28.8M+3.5%	$27.8M-0.7%	$28.0M	$16.0M+94.0%	$8.2M	$9.5M+53.0%	$6.2M+48.4%	$4.2M
SG&A Expenses	$125.6M	$130.7M	$150.0M+2.3%	$146.6M-4.3%	$153.3M	$161.4M+1.5%	$159.0M	$138.0M+15.6%	$119.4M-6.2%	$127.3M+16.0%	$109.7M	$99.2M+16.9%	$84.9M	$62.4M-6.5%	$66.8M+14.9%	$58.1M
Operating Income	-$85.3M	-$46.6M	$22.9M-0.3%	$22.9M-66.2%	$67.9M	$193.5M+4.7%	$184.9M	$112.1M+21.3%	$92.4M+0.6%	$91.9M+19.9%	$76.7M	$75.1M-26.2%	$101.7M	$90.7M-24.3%	$119.8M+32.4%	$90.5M
EBITDA	N/A	$9.0M	$89.2M-8.0%	$97.0M-28.3%	$135.3M	$253.9M+3.0%	$246.5M	$174.0M+12.7%	$154.4M+0.8%	$153.2M+14.5%	$133.8M	$122.7M-13.3%	$141.6M	$121.5M-13.3%	$140.2M+34.8%	$104.0M
Interest Expense	$51.4M	$49.4M	$48.4M+13.3%	$42.7M+124.9%	$19.0M	-$6.2M+30.0%	-$8.9M	$11.6M+96.1%	$5.9M+506.3%	$975K+20.2%	$811K	$160K+201.9%	$53K	$52K-43.5%	$92K-51.1%	$188K
Income Tax	$36.9M	$36.0M	-$5.2M-15.6%	-$4.5M-136.4%	$12.3M	$33.5M-8.8%	$36.8M	$18.7M+9.9%	$17.0M-34.6%	$26.0M+5.9%	$24.5M	$24.9M-27.0%	$34.1M	$30.9M-26.2%	$41.9M+40.0%	$29.9M
Net Income	-$173.7M	-$132.0M	-$20.3M-32.9%	-$15.3M-141.8%	$36.6M	$153.7M+10.4%	$139.2M	$81.8M+17.7%	$69.5M+6.9%	$65.1M+26.6%	$51.4M	$50.5M-25.7%	$68.0M	$60.1M-23.1%	$78.1M+29.1%	$60.5M
EPS (Basic)	N/A	-$5.77	-$0.90-32.4%	-$0.68-141.7%	$1.63	$6.40+27.2%	$5.03	$2.78+41.1%	$1.97+24.7%	$1.58+42.3%	$1.11	$0.99-22.0%	$1.27	$1.10-22.0%	$1.41+28.2%	$1.10
EPS (Diluted)	—	-$5.77	-$0.90-32.4%	-$0.68-142.5%	$1.60	$6.16+25.7%	$4.90	$2.70+40.6%	$1.92+23.9%	$1.55+40.9%	$1.10	$0.97-22.4%	$1.25	$1.08-21.2%	$1.37+28.0%	$1.07
Diluted Shares (Avg)	N/A	23M	23M+0.8%	22M-1.9%	23M	25M-12.2%	28M	30M-16.1%	36M-14.1%	42M-10.3%	47M	52M-3.9%	54M	56M-2.2%	57M+1.1%	56M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$319.0M-18.9%	$347.4M-7.8%	$342.9M-19.6%	$327.9M-19.7%	$393.3M-16.4%	$376.8M-12.3%	$426.6M-9.7%	$408.4M-11.0%
Cost of Revenue	$134.4M-12.0%	$154.1M+1.9%	$137.5M-17.7%	$134.2M-19.6%	$152.7M-21.4%	$151.2M-19.0%	$167.1M-17.1%	$166.9M-14.2%
Gross Profit	$184.6M-23.2%	$193.3M-14.3%	$205.4M-20.9%	$193.7M-19.8%	$240.5M-12.9%	$225.6M-7.1%	$259.5M-4.3%	$241.5M-8.6%
R&D Expenses	$5.3M-50.9%	$6.3M-40.9%	$7.3M-30.8%	$9.4M-18.6%	$10.9M-12.4%	$10.7M-19.8%	$10.6M-16.2%	$11.6M-25.0%
SG&A Expenses	$33.6M-13.0%	$30.7M-19.8%	$31.8M-3.9%	$29.6M-25.2%	$38.6M-1.2%	$38.2M+7.8%	$33.1M+3.5%	$39.6M-0.6%
Operating Income	-$36.9M-2092.2%	-$8.1M-389.8%	-$40.3M-578.1%	-$75K-101.2%	$1.9M-66.6%	$2.8M+114.2%	$8.4M+56.5%	$6.1M-45.5%
EBITDA	-$24.5M-246.7%	N/A	N/A	N/A	$16.7M-27.5%	N/A	N/A	N/A
Interest Expense	$13.1M+18.2%	$13.9M+18.2%	$12.7M+5.2%	$11.7M-4.4%	$11.1M-9.9%	$11.7M-62.0%	$12.1M+10.0%	$12.3M+23.3%
Income Tax	$338K+157.8%	$36.6M+950.8%	-$13.2M-2601.8%	$13.2M+1301.4%	-$585K-180.7%	-$4.3M+39.5%	-$489K+85.0%	-$1.1M-309.7%
Net Income	-$50.3M-481.7%	-$58.6M-1155.1%	-$39.8M-1168.8%	-$25.0M-395.2%	-$8.6M-15.6%	-$4.7M+81.5%	-$3.1M-35.3%	-$5.1M-769.9%
EPS (Basic)	-$2.19-476.3%	N/A	-$1.73-1135.7%	-$1.09-395.5%	-$0.38-15.2%	N/A	-$0.14-40.0%	-$0.22-833.3%
EPS (Diluted)	-$2.19-476.3%	N/A	-$1.73-1135.7%	-$1.09-395.5%	-$0.38-15.2%	N/A	-$0.14-40.0%	-$0.22-833.3%
Diluted Shares (Avg)	23M+1.3%	N/A	23M+1.4%	23M+1.3%	23M+0.9%	N/A	23M+0.7%	23M+0.5%

SNBR Balance Sheet

SNBR quarterly balance sheet

Metric	FY2610-K	FY2410-K	FY2310-K	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Total Assets	$641.0M	$860.8M-9.5%	$950.9M-0.3%	$953.9M	$912.6M+11.0%	$822.2M	$806.0M+71.4%	$470.1M-0.4%	$471.8M+3.2%	$457.2M	$481.0M-2.3%	$492.5M	$381.8M+11.6%	$342.0M+30.2%	$262.7M
Current Assets	$143.5M	$181.3M-12.1%	$206.1M+4.2%	$197.8M	$191.9M+11.9%	$171.5M	$160.4M+6.3%	$150.9M-1.1%	$152.5M+10.2%	$138.3M	$172.3M-26.8%	$235.5M	$189.5M-10.0%	$210.6M+10.1%	$191.2M
Cash & Equivalents	$1.5M	$1.9M-23.2%	$2.5M+41.7%	$1.8M	$1.6M-30.5%	$2.2M	$1.6M-1.2%	$1.6M-55.8%	$3.7M-68.6%	$11.6M	$29.5M+13.2%	$26.1M	$58.2M-33.8%	$87.9M-24.4%	$116.3M
Short-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	$78.2M	$103.2M-10.6%	$115.4M+1.2%	$114.0M	$103.2M+25.4%	$82.3M	$87.1M+2.6%	$84.9M+0.7%	$84.3M+12.4%	$75.0M	$81.0M+44.6%	$56.0M	$40.2M+12.9%	$35.6M+43.1%	$24.9M
Accounts Receivable	$13.4M	$17.5M-34.8%	$26.9M+3.3%	$26.0M	$24.5M-5.5%	$25.9M	$20.0M-19.4%	$24.8M+28.4%	$19.3M-2.0%	$19.7M	$20.2M+12.9%	$17.9M	$15.0M-9.8%	$16.6M+20.0%	$13.8M
Long-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$64.0M	$64.0M0.0%	$64.0M0.0%	$64.0M	$64.0M0.0%	$64.0M	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M	$64.0M+611.1%	$9.0M	$9.0M+214.5%	$2.9M0.0%	$2.9M
Total Liabilities	$1.3B	$1.3B-5.8%	$1.4B0.0%	$1.4B	$1.4B+19.7%	$1.2B	$965.5M+66.6%	$579.7M+51.5%	$382.7M+28.9%	$296.8M	$293.8M+32.2%	$222.2M	$156.5M+5.5%	$148.3M+11.3%	$133.3M
Current Liabilities	$931.7M	$908.0M-3.0%	$936.1M+0.7%	$929.8M	$937.9M+23.8%	$757.4M	$594.8M+21.7%	$488.7M+59.5%	$306.4M+36.0%	$225.3M	$220.2M+18.2%	$186.3M	$137.2M+3.1%	$133.1M+11.8%	$119.0M
Non-Current Liabilities	$335.6M	$404.4M-11.5%	$456.7M-1.2%	$462.3M	$443.9M+11.7%	$397.5M	$370.7M+307.3%	$91.0M+19.3%	$76.3M+6.7%	$71.5M	$73.6M+105.1%	$35.9M	$19.4M+26.9%	$15.3M-88.5%	$133.3M
Total Equity	-$626.3M	-$451.6M-2.2%	-$441.9M-0.9%	-$438.2M	-$469.2M-41.1%	-$332.6M	-$159.4M-45.5%	-$109.5M-222.9%	$89.2M-44.4%	$160.3M	$187.2M-30.7%	$270.3M	$225.2M+16.3%	$193.7M+49.7%	$129.4M
Retained Earnings	-$661.5M	-$479.2M-4.4%	-$458.9M-3.4%	-$443.6M	-$469.4M-41.0%	-$332.9M	-$159.7M-45.4%	-$109.9M-223.8%	$88.8M-44.5%	$159.9M	$186.7M-30.8%	$269.7M	$219.3M+37.7%	$159.2M+96.3%	$81.1M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$641.0M-23.4%	$680.1M-21.0%	$749.4M-13.3%	$804.5M-9.0%	$836.8M-7.9%	$860.8M-9.5%	$864.7M-10.0%	$883.6M-8.4%
Current Assets	$143.5M-18.2%	$150.0M-17.3%	$169.8M-0.3%	$175.5M-1.0%	$175.4M-3.1%	$181.3M-12.1%	$170.3M-14.0%	$177.4M-14.9%
Cash & Equivalents	$1.5M-12.2%	$1.7M-13.2%	$1.3M-20.6%	$1.3M-33.2%	$1.7M-18.2%	$1.9M-23.2%	$1.6M+75.7%	$2.0M+12.3%
Inventory	$78.2M-24.7%	$82.2M-20.3%	$89.8M-3.4%	$99.5M+3.8%	$103.9M+2.9%	$103.2M-10.6%	$93.0M-19.9%	$95.8M-21.1%
Accounts Receivable	$13.4M-6.1%	$15.5M-11.5%	$13.9M-18.3%	$16.0M-21.0%	$14.2M-34.8%	$17.5M-34.8%	$17.0M-8.6%	$20.3M-15.9%
Goodwill	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%
Total Liabilities	$1.3B-2.0%	$1.3B-4.1%	$1.3B-3.3%	$1.3B-3.4%	$1.3B-4.5%	$1.3B-5.8%	$1.3B-4.9%	$1.3B-3.9%
Current Liabilities	$931.7M+3.0%	$912.5M+0.5%	$898.8M+0.5%	$903.2M+0.3%	$904.4M-0.2%	$908.0M-3.0%	$894.0M-2.8%	$900.6M-2.3%
Non-Current Liabilities	$335.6M-13.8%	$346.0M-14.4%	$371.9M-11.3%	$382.0M-11.2%	$389.3M-13.1%	$404.4M-11.5%	$419.4M-9.3%	$430.0M-7.0%
Total Equity	-$626.3M-37.1%	-$578.5M-28.1%	-$521.3M-16.2%	-$480.7M-7.5%	-$456.8M-2.5%	-$451.6M-2.2%	-$448.8M-6.7%	-$447.0M-6.6%
Retained Earnings	-$661.5M-35.6%	-$611.2M-27.5%	-$552.6M-16.5%	-$512.9M-8.8%	-$487.8M-4.6%	-$479.2M-4.4%	-$474.5M-9.4%	-$471.4M-9.3%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Long-Term Debt.

SNBR Cash Flow Statement

SNBR quarterly cash flow statement

Metric	TTM	FY2610-K	FY2410-K	FY2310-K	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Operating Cash Flow	-$8.4M	-$3.3M	$27.1M+400.7%	-$9.0M-125.0%	$36.1M	$300.0M+7.3%	$279.7M	$189.2M+43.8%	$131.5M-23.8%	$172.6M+13.8%	$151.6M	$107.9M-25.3%	$144.5M	$88.1M-12.4%	$100.6M+10.5%	$91.0M
Depreciation & Amortization	N/A	$55.6M	$66.4M-10.4%	$74.0M+9.9%	$67.4M	$60.4M-1.9%	$61.6M	$61.9M-0.2%	$62.0M+1.1%	$61.3M+7.2%	$57.2M	$47.6M+19.6%	$39.8M	$30.8M+51.0%	$20.4M+50.6%	$13.5M
Stock-Based Compensation	N/A	$6.3M	$11.4M-23.0%	$14.9M+12.3%	$13.2M	$23.2M+6.4%	$21.8M	$16.7M+46.0%	$11.4M-27.6%	$15.8M+31.8%	$12.0M	$10.3M+51.4%	$6.8M	$4.2M-58.9%	$10.3M+107.3%	$5.0M
Capital Expenditures	$15.2M	$14.4M	$23.5M-58.8%	$57.1M-17.9%	$69.5M	$66.9M+80.3%	$37.1M	$59.2M+30.2%	$45.5M-23.9%	$59.8M+3.4%	$57.9M	$85.6M+11.7%	$76.6M	$76.8M+48.9%	$51.6M+119.3%	$23.5M
Free Cash Flow	-$23.7M	-$17.7M	$3.6M+105.5%	-$66.1M-98.4%	-$33.3M	$233.1M-3.9%	$242.6M	$129.9M+51.0%	$86.0M-23.7%	$112.8M+20.2%	$93.8M	$22.4M-67.1%	$67.9M	$11.3M-77.0%	$49.0M-27.4%	$67.5M
Investing Cash Flow	-$18.5M	-$17.7M	-$26.3M+54.9%	-$58.4M+17.4%	-$70.6M	-$66.6M-70.8%	-$39.0M	-$56.6M-25.2%	-$45.2M+24.3%	-$59.8M-40.1%	-$42.7M	N/A	N/A	-$87.3M+22.1%	-$112.1M-99.5%	-$56.2M
Financing Cash Flow	$26.7M	$20.7M	-$1.4M-102.1%	$68.1M+101.1%	$33.9M	-$235.2M+1.2%	-$238.0M	-$132.6M-50.1%	-$88.3M+28.7%	-$123.9M-4.7%	-$118.4M	N/A	N/A	-$30.5M-80.8%	-$16.9M-413.5%	$5.4M
Share Buybacks	$1.0M	$1.2M	$768K-79.5%	$3.7M-94.2%	$64.2M	$382.4M+62.3%	$235.6M	$165.1M-39.4%	$272.4M+75.5%	$155.2M+22.5%	$126.7M	$100.2M+115.5%	$46.5M	$42.1M+20.6%	$34.9M+9304.9%	$371K

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	-$7.8M-195.2%	$1.9M+107.9%	-$6.4M-123.3%	$3.8M+137.4%	-$2.6M-107.8%	-$23.7M+42.0%	$27.3M+108.5%	-$10.2M-7457.6%
Depreciation & Amortization	$12.4M-16.6%	N/A	N/A	N/A	$14.8M-15.2%	N/A	N/A	N/A
Stock-Based Compensation	$2.8M-28.5%	N/A	-$788K-155.0%	$1.5M-61.2%	$4.0M-4.0%	N/A	$1.4M+45.8%	$4.0M-24.0%
Capital Expenditures	$5.4M+18.3%	$2.5M-59.9%	$3.8M+22.0%	$3.5M-27.6%	$4.6M-50.6%	$6.3M-30.4%	$3.1M-82.7%	$4.8M-66.8%
Free Cash Flow	-$13.2M-82.6%	-$643K+97.9%	-$10.2M-142.2%	$369K+102.5%	-$7.2M-129.6%	-$30.0M+39.9%	$24.2M+580.7%	-$15.0M-5.6%
Investing Cash Flow	-$5.4M-18.3%	-$2.5M+59.9%	-$3.8M-28.4%	-$6.7M-41.2%	-$4.6M+62.5%	-$6.3M+30.3%	-$3.0M+84.3%	-$4.8M+67.7%
Financing Cash Flow	$13.0M+86.4%	$1.1M-96.5%	$10.1M+140.8%	$2.6M-82.8%	$7.0M+131.7%	$30.3M-41.1%	-$24.7M-594.2%	$14.9M-0.2%
Share Buybacks	$373K-33.7%	$194K+385.0%	$75K-35.3%	$381K+807.1%	$563K-1.2%	$40K+11.1%	$116K-44.8%	$42K-69.6%

Not reported in any period shown, so not listed: Dividends Paid.

SNBR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNBR quarterly financial ratios

Metric	FY2610-K	FY2410-K	FY2310-K	FY22	FY22	FY21	FY19	FY18	FY17	FY16	FY16	FY15	FY13	FY12	FY11
Gross Margin	59.0%	59.6%+1.9pp	57.7%+0.8pp	56.9%	60.4%-1.9pp	62.3%	61.9%+1.3pp	60.6%-1.5pp	62.1%+0.3pp	61.8%	61.0%-0.1pp	61.1%	62.7%-1.1pp	63.8%+0.5pp	63.3%
Operating Margin	-3.3%	1.4%+0.1pp	1.2%-2.0pp	3.2%	8.9%-1.1pp	10.0%	6.6%+0.6pp	6.0%-0.3pp	6.4%+0.5pp	5.9%	6.2%-2.6pp	8.8%	9.4%-3.4pp	12.8%+0.6pp	12.2%
Net Margin	-9.3%	-1.2%-0.4pp	-0.8%-2.5pp	1.7%	7.0%-0.5pp	7.5%	4.8%+0.3pp	4.5%0.0pp	4.5%+0.6pp	3.9%	4.2%-1.7pp	5.9%	6.3%-2.1pp	8.3%+0.2pp	8.1%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	73.0%+40.9pp	32.1%	27.0%+1.8pp	25.1%	26.7%-13.6pp	40.3%-6.4pp	46.7%
Return on Assets	-20.6%	-2.4%-0.8pp	-1.6%-5.4pp	3.8%	16.8%-0.1pp	16.9%	10.2%-4.6pp	14.8%+1.0pp	13.8%+2.5pp	11.3%	10.5%-3.3pp	13.8%	15.7%-7.1pp	22.8%-0.2pp	23.0%
Current Ratio	0.15	0.200.0x	0.220.0x	0.21	0.200.0x	0.23	0.270.0x	0.31-0.2x	0.50-0.1x	0.61	0.78-0.5x	1.26	1.38-0.2x	1.580.0x	1.61
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	4.29+2.4x	1.85	1.57+0.7x	0.82	0.70-0.1x	0.77-0.3x	1.03
Asset Turnover	2.20	1.950.0x	1.99-0.2x	2.22	2.39+0.1x	2.26	2.11-1.2x	3.26+0.2x	3.06+0.2x	2.87	2.52+0.2x	2.35	2.52-0.2x	2.73-0.1x	2.83
FCF Margin	-1.3%	0.2%+3.7pp	-3.5%-1.9pp	-1.6%	10.7%-2.4pp	13.1%	7.6%+2.0pp	5.6%-2.2pp	7.8%+0.7pp	7.1%	1.8%-4.0pp	5.9%	1.2%-4.1pp	5.2%-3.8pp	9.1%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	57.9%-3.3pp	55.6%-4.2pp	59.9%-0.9pp	59.1%-0.1pp	61.2%+2.5pp	59.9%+3.3pp	60.8%+3.5pp	59.1%+1.5pp
Operating Margin	-11.6%-12.0pp	-2.3%-3.1pp	-11.8%-13.7pp	0.0%-1.5pp	0.5%-0.7pp	0.7%+5.3pp	2.0%+0.8pp	1.5%-1.0pp
Net Margin	-15.8%-13.6pp	-16.9%-15.6pp	-11.6%-10.9pp	-7.6%-6.4pp	-2.2%-0.6pp	-1.2%+4.6pp	-0.7%-0.3pp	-1.2%-1.4pp
Return on Assets	-7.8%-6.8pp	-8.6%-8.1pp	-5.3%-5.0pp	-3.1%-2.5pp	-1.0%-0.2pp	-0.5%+2.1pp	-0.4%-0.1pp	-0.6%-0.7pp
Current Ratio	0.150.0x	0.160.0x	0.190.0x	0.190.0x	0.190.0x	0.200.0x	0.190.0x	0.200.0x
Asset Turnover	0.500.0x	0.51+0.1x	0.460.0x	0.41-0.1x	0.470.0x	0.440.0x	0.490.0x	0.460.0x
FCF Margin	-4.1%-2.3pp	-0.2%+7.8pp	-3.0%-8.6pp	0.1%+3.8pp	-1.8%-7.0pp	-8.0%+3.7pp	5.7%+6.7pp	-3.7%-0.6pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$626.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.15), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Sleep Number Corporation SNBR	FY2026	$1.4B	-$132.0M	-9.3%	$2.9M	25/100
Viomi Technology Co., Ltd VIOT	FY2025	$347.2M	$20.3M	5.9%	$104.2M	66/100
The Lovesac Company LOVE	FY2026	$697.1M	$4.1M	0.6%	$210.3M	40/100
Flexsteel Industries FLXS	FY2026	$459.2M	$33.1M	7.2%	$356.3M	58/100
Hamilton Beach Brands Holding Company HBB	FY2025	$606.9M	$26.5M	4.4%	$463.5M	63/100
Traeger, Inc. COOK	FY2025	$559.5M	-$115.2M	-20.6%	$138.1M	34/100

Where Sleep Number Corporation Ranks

Frequently Asked Questions

What is Sleep Number Corporation's annual revenue?

Sleep Number Corporation (SNBR) reported $1.4B in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Sleep Number Corporation profitable?

No, Sleep Number Corporation (SNBR) reported a net income of -$132.0M in fiscal year 2026, with a net profit margin of -9.3%.

What is Sleep Number Corporation's EBITDA?

Sleep Number Corporation (SNBR) had EBITDA of $9.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Sleep Number Corporation's gross margin?

Sleep Number Corporation (SNBR) had a gross margin of 59.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sleep Number Corporation's operating margin?

Sleep Number Corporation (SNBR) had an operating margin of -3.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Sleep Number Corporation's net profit margin?

Sleep Number Corporation (SNBR) had a net profit margin of -9.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Sleep Number Corporation's free cash flow?

Sleep Number Corporation (SNBR) recorded an outflow of $17.7M in free cash flow during fiscal year 2026. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sleep Number Corporation's operating cash flow?

Sleep Number Corporation (SNBR) recorded an outflow of $3.3M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are Sleep Number Corporation's total assets?

Sleep Number Corporation (SNBR) had $641.0M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Sleep Number Corporation's capital expenditures?

Sleep Number Corporation (SNBR) invested $14.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Sleep Number Corporation spend on research and development?

Sleep Number Corporation (SNBR) invested $33.9M in research and development during fiscal year 2026.

Does Sleep Number Corporation buy back shares?

Yes, Sleep Number Corporation (SNBR) spent $1.2M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Sleep Number Corporation have outstanding?

Sleep Number Corporation (SNBR) had 23M shares outstanding as of fiscal year 2026.

What is Sleep Number Corporation's current ratio?

Sleep Number Corporation (SNBR) had a current ratio of 0.15 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

What is Sleep Number Corporation's return on assets (ROA)?

Sleep Number Corporation (SNBR) had a return on assets of -20.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

How does Sleep Number Corporation's liquidity compare with its operating cash outflow?

At the end of fiscal year 2026, Sleep Number Corporation (SNBR) held $1.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.3M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is Sleep Number Corporation's debt-to-equity ratio negative or not reported?

Sleep Number Corporation (SNBR) has negative shareholder equity of -$626.3M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Sleep Number Corporation's Altman Z-Score?

Sleep Number Corporation (SNBR) has an Altman Z-Score of -0.96, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Sleep Number Corporation's Piotroski F-Score?

Sleep Number Corporation (SNBR) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sleep Number Corporation's earnings high quality?

Sleep Number Corporation (SNBR) reported a net loss of $132.0M while operations used $3.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Sleep Number Corporation cover its interest payments?

Sleep Number Corporation (SNBR) reported an operating loss of $46.6M against $49.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Sleep Number Corporation?

Sleep Number Corporation (SNBR) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.